These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10112859)

  • 1. Time to leave the capsule ... if you dare.
    McCarthy R
    Bus Health; 1991 Sep; 9(9):22-3, 26, 28 passim. PubMed ID: 10112859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
    Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
    [No Abstract]   [Full Text] [Related]  

  • 3. State and federal government mandates are changing the face of pharmacy management.
    Giaquinta D
    Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
    [No Abstract]   [Full Text] [Related]  

  • 4. Plans continue to raise copayments.
    Manag Care; 2005 Sep; 14(9):59. PubMed ID: 16238260
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacy benefits for Medicare: a "triple-edged" sword.
    Penna P
    Manag Care Interface; 2001 Oct; 14(10):57-8. PubMed ID: 11688094
    [No Abstract]   [Full Text] [Related]  

  • 6. Need for integrated data in pharmacy benefits.
    Martens G; Clor GE
    J Health Care Benefits; 1993; 3(1):57-60. PubMed ID: 10130352
    [No Abstract]   [Full Text] [Related]  

  • 7. MCO-PBM (managed care organization-prescription benefit management) partnerships holding down drug trend.
    Alexander W
    Exec Solut Healthc Manag; 1998 Dec; 1(10):1, 4-6. PubMed ID: 10338773
    [No Abstract]   [Full Text] [Related]  

  • 8. By the numbers. The rising costs of prescription drugs.
    Thornton D
    Healthplan; 1999; 40(5):71-2. PubMed ID: 10622972
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry warily eyes new Medicare drug plan.
    Vastag B
    Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141
    [No Abstract]   [Full Text] [Related]  

  • 10. Affordable prescription drugs--state and federal action.
    Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
    [No Abstract]   [Full Text] [Related]  

  • 11. Go beyond demographics to get a handle on pharmacy costs.
    Capitation Manag Rep; 2001 Feb; 8(2):24-5, 17. PubMed ID: 11234360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving role of pharmacy benefits management firms in a managed care environment.
    O'Leary JS
    Benefits Q; 1995; 11(3):24-33. PubMed ID: 10151118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the market ready for direct pharmaceutical contracting by employers?
    Giaquinta D
    Manag Care Interface; 2004 Aug; 17(8):33-4. PubMed ID: 15471109
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

  • 15. Employers push to manage prescription drug costs.
    Frieden J
    Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of drug reimportation on managed care pharmacy.
    Penna P
    Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of randomized controlled trials in organizational decision making: a cost-minimization approach.
    Cher DJ; Maclure M
    Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501
    [No Abstract]   [Full Text] [Related]  

  • 18. Vertical integration: the drug industry and prescription benefits managers.
    Gibaldi M
    Pharmacotherapy; 1995; 15(3):265-71. PubMed ID: 7667161
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of prescription costs--is it possible?
    Renaud PN
    Empl Benefits J; 2002 Mar; 27(1):11-4. PubMed ID: 11859536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The misperception of managed care PPOs by pharmaceutical companies.
    Elden DL
    AAPPO J; 1993; 3(1):9, 43-4. PubMed ID: 10148644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.